The MAPK pathway as an apoptosis enhancer in melanoma

Inhibition of RAF/MEK/ERK signaling is beneficial for many patients with BRAF(V600E)–mutated melanoma. However, primary and secondary resistances restrict long-lasting therapy success. Combination therapies are therefore urgently needed. Here, we evaluate the cellular effect of combining a MEK inhib...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Haydn, Johannes M., Hufnagel, Anita, Grimm, Johannes, Maurus, Katja, Schartl, Manfred, Meierjohann, Svenja
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2014
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4148120/
https://ncbi.nlm.nih.gov/pubmed/24970815
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak